NUWE — Nuwellis, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1506492 ·
Last close
$1.05
Market Cap
$3.33M
52W High
$34.65
52W Low
$1.05
ADV30
6,088,123
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,403,000 | 1,684,000 | -4,568,000 | -4,541,000 | 6,961,000 | 2,083,000 | 4,292,000 |
| Dec 2025 | 2,424,000 | 1,654,000 | -2,443,000 | -2,422,000 | 6,118,000 | 1,085,000 | 3,488,000 |
| Sep 2025 | 2,217,000 | 1,445,000 | -2,697,000 | 468,000 | 7,984,000 | 3,094,000 | 4,070,000 |
| Jun 2025 | 1,725,000 | 958,000 | -2,906,000 | -12,553,000 | 9,200,000 | 4,450,000 | 18,155,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,386,000
Investing CF
$-374,000
Financing CF
$11,335,000
CapEx
$-241,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2239.85
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-320,853,000
Inventory
$1,779,000
Receivables
$1,559,000
ST Investments
—
EBIT TTM
$-8,518,000
Pretax Income TTM
$-19,044,000
Interest Exp TTM
$10,553,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$9,013,000
EBITDA
$-12,725,000
Free Cash Flow
$-11,442,250
Enterprise Value
$518,826
Total Cash
$3,922,000
Total Debt
$200,000
Shares Out
3,175,134
Trailing EPS
$2548.34
Book Value
$-3.58
ROE
-609.4%
ROA
-87.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 8,270,000 | -11,106,000 | -17,521,000 | 6,118,000 | 3,488,000 | — | -10,810,000 |
| Dec 2024 | 8,740,000 | -10,988,000 | -11,165,000 | 9,864,000 | 3,334,000 | — | -9,591,000 |
| Dec 2023 | 8,864,000 | -17,630,000 | -20,209,000 | 9,770,000 | 6,559,000 | — | -17,937,000 |
| Dec 2022 | 8,543,000 | -17,171,000 | -14,525,000 | 24,673,000 | 12,316,000 | — | -15,149,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.59
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TUTH | Standard Dental Labs Inc. | $3.20M | $0.10 | — |
| GCTK | Glucotrack, Inc. | $3.52M | $0.33 | — |
| NXGL | NEXGEL, INC. | $3.70M | $0.38 | — |
| STME | Stimcell Energetics Inc. | $4.04M | $0.19 | — |
| ADMT | ADM TRONICS UNLIMITED, INC. | $2.70M | $0.04 | — |
News headlines (Yahoo Finance, 1h cache)
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical
2026-08-25 12:30 · Yahoo
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ...
2026-08-13 23:05 · Yahoo
Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin
2026-08-13 12:00 · Yahoo
Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface
2026-08-11 07:30 · Yahoo
Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
2026-07-31 12:39 · Yahoo
Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy
2026-07-30 12:00 · Yahoo
Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth
2026-07-27 12:30 · Yahoo
Nuwellis’ new CEO on building a strong foundation for sustainable value creation
2026-07-27 12:11 · Yahoo
Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies
2026-07-16 12:30 · Yahoo
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026
2026-07-07 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.